Zonisade — Medica
adjunctive therapy for the treatment of partial-onset seizures in adults and pediatric patients ≥ 16 years of age with epilepsy
Preferred products
- generic zonisamide capsules
Initial criteria
- Patient has tried one Step 1 Product (generic zonisamide capsules)
- OR patient cannot swallow or has difficulty swallowing solid oral dosage forms (for Zonisade only)
Approval duration
1 year